title: Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease.
authors.affiliation: Department of Radiology, University of Utah, Salt Lake City, UT, USA.
authors.forename: Gang
authors.initials: G
authors.lastname: Liu
authors.forename: Ping
authors.initials: P
authors.lastname: Men
authors.forename: George
authors.initials: G
authors.lastname: Perry
authors.forename: Mark A
authors.initials: MA
authors.lastname: Smith
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D019281:Dimerization; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D015195:Drug Design; D006801:Humans; D007502:Iron Chelating Agents / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D053758:Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use; D036103:Nanotechnology / Q000379:methods* / Q000639:trends; D009480:Neuropharmacology / Q000379:methods* / Q000639:trends; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology
chemical_list: D007502:Iron Chelating Agents